2009-11-09 23:59:03 -
Alfacell Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com
www.companiesandmarkets.com/Summary-Company-Profile/alfacell-cor ..
Alfacell Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
Alfacell Corporation is a biopharmaceutical company engaged in developing drugs for the treatment of cancer and other pathological conditions. It is the first company to develop a biopharmaceutical product candidate that works similar to RNA interference (RNAi) through late-stage clinical trials. The major product candidate of the company is ONCONASE, an RNase that overcomes the challenges of targeting RNA for therapeutic purposes while enabling the development of a new class of targeted therapies for cancer and other life-threatening diseases. ONCONASE is currently going through the third phase of clinical trials for the treatment of different varieties of cancer.
The Alfacell Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile is
an essential source for company data and information. The profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.